SELFJECT Trademark

Trademark Overview

On Friday, March 8, 2024, a trademark application was filed for SELFJECT with the United States Patent and Trademark Office. The USPTO has given the SELFJECT trademark a serial number of 98440102. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 11, 2025. This trademark is owned by Mallinckrodt Pharmaceuticals Ireland Limited. The SELFJECT trademark is filed in the Pharmaceutical Products category with the following description:

An injection device pre-filled with pharmaceutical preparations for the treatment of auto-immune disorders.
selfject

General Information

Serial Number98440102
Word MarkSELFJECT
Filing DateFriday, March 8, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements

Goods and ServicesAn injection device pre-filled with pharmaceutical preparations for the treatment of auto-immune disorders.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 8, 2024
Primary Code005
First Use Anywhere DateTuesday, August 6, 2024
First Use In Commerce DateTuesday, August 6, 2024

Trademark Owner History

Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin D15TX2V
IE
Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin D15TX2V
IE

Trademark Events

Event DateEvent Description
Friday, March 8, 2024NEW APPLICATION ENTERED
Friday, March 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 6, 2024TEAS AMENDMENT OF USE RECEIVED
Tuesday, August 6, 2024AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, August 6, 2024USE AMENDMENT FILED
Friday, September 20, 2024ASSIGNED TO EXAMINER
Monday, October 7, 2024NON-FINAL ACTION E-MAILED
Monday, October 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 7, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 15, 2025FINAL REFUSAL E-MAILED
Wednesday, January 15, 2025FINAL REFUSAL WRITTEN
Wednesday, January 15, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 6, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, February 6, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, February 14, 2025PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, February 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 14, 2025USE AMENDMENT ACCEPTED
Friday, February 14, 2025ALLEGED AMENDMENT TO USE WITHDRAWN
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 6, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED

Related Keywords

selfject auto immune disorders treatment preparations device filled pharmaceutical injection